News | 2018.07.02
The square known as "Place Daniel Iffla-Osiris", at the junction of boulevard Haussmann and boulevard des Italiens in Paris, was officially opened on June 27, 2018. This inauguration is an ideal opportunity to look back on the story of Daniel Iffla-Osiris, one of the greatest philanthropists of the 19th century. At his death in 1907, he left behind the largest legacy ever received by the Institut...
Document de presse | 2018.11.22
Professor Pascale Cossart of the Institut Pasteur in Paris will be honoured with the 2018 Heinrich Wieland Prize for her fundamental contributions to Molecular Infection Biology. Cossart’s innovative research has unravelled how pathogenic bacteria, in particular food-borne Listeria, enter human cells, use the host cells’ own mechanisms to do so, and trick and evade the immune system. Her...
Fiche maladie | 2019.06.25
Lassa fever is an acute viral disease belonging to the category of viral hemorrhagic fevers, similar to Ebola. It is mainly found in West Africa and is caused by the Lassa virus, which is transmitted to humans through contact with infected rodents. Although many cases of infection are asymptomatic, the disease may be severe and potentially fatal.
Portrait | 2018.12.04
It was 35 years ago that the HIV-1 virus, responsible for AIDS, was first isolated by scientists at the Institut Pasteur. While many lives have been saved by antiretroviral therapy, there is currently no treatment that fully eliminates the virus from the body, and the search for a vaccine goes on. These challenges are driving the research of a number of scientists at the Institut Pasteur,...
News | 2019.10.25
On October 8, 2019, the Université libre de Bruxelles inaugurated an exhibition entitled "100th anniversary of a Nobel Prize – Jules Bordet". Developed in collaboration with the Institut Pasteur, this exhibition pays tribute to Institut Pasteur scientist Jules Bordet, who was awarded the 1919 Nobel Prize in Physiology or Medicine for his work on immunity. The exhibition will run until December 21...
Document de presse | 2020.01.30
On January 24, 2020, the French Ministry of Health confirmed the first three cases of patients affected by coronavirus, 2019-nCoV. On January 29, 2020, the Institut Pasteur, which is responsible for monitoring respiratory viruses in France, sequenced the whole genome of the coronavirus known as "2019-nCoV", becoming the first institution in Europe to sequence the virus since the start of the...
News | 2020.02.14
Leishmaniasis is a human and animal disease caused by parasites of the Leishmania genus that affects 12 million people worldwide. It is endemic in around a hundred countries and is currently emerging in Europe as a result of climate change and large-scale population movements. Scientists from the Institut Pasteur in Paris, in collaboration with the Institut Pasteur of Shanghai-Chinese Academy of...
Document de presse | 2020.06.23
In late April 2020, scientists at the Institut Pasteur, with the support of the Hauts-de-France Regional Health Agency and the Amiens Education Authority, carried out an epidemiological survey on 1,340 people linked to primary schools in Crépy-en-Valois, in the Oise department. Thanks to the cooperation of the people of Crépy-en-Valois, the survey, which made use of serological tests developed by...
Document de presse | 2020.10.15
Innate immunity is the fastest-acting component of the immune system, but so far little is known about its role during infection with SARS-CoV-2. A few hours after an infection, the body emits an alarm signal, interferon, enabling cells that have not yet been infected to produce antiviral proteins. This phenomenon occurs well before the production of neutralizing antibodies. Scientists from the...
Document de presse | 2020.10.08
A further step has just been taken in understanding the mechanisms that allow some individuals to control HIV infection without treatment.A research team led by Dr. Asier Sáez-Cirión (Institut Pasteur) and Dr. Bruno Vaslin (IDMIT[1], CEA-Inserm-Université Paris Saclay) observed for the first time that the antiviral activity of CD8+ T cells of "controller" macaques infected with the simian...